Doublewin Biological Technology Co., Ltd.(expird)
Free supplier Enterprise Certification
- Free
supplier - 4th
years
Free supplier Enterprise Certification
Business Type:Lab/Research institutions
Product Certification&
Enterprise Certification
Country: 
China (Mainland)
Business Type:Lab/Research institutions
CAS NO.33515-09-2
A(1-10)Metric TonA(20-50)Metric Ton
Quality
1. High quality and competitive price.
2. All purity> 99%.
3. We are a manufacturer and can provide high-quality products at ex-factory prices.
Fast and safe delivery.
Delivery
1. The package will be sent out within 24 hours of receiving the remittance.
2. Safe and prudent transportation method for you to choose.
3. Customs pass rate> 99%.
Service
1. Professional service and rich experience make customers feel at ease, sufficient inventory and fast delivery meet their needs.
6. Can provide NMR, HPLC and COA
5. Welcome to order samples.
After-sales
1. Communicate face to face via phone/WeChat/WhatsApp/skype. We are experts and your friends!
2. Market feedback and product feedback will be greatly appreciated. It is our responsibility to meet customer requirements.
3. Doublewin company exports the goods to many countries and regions at reasonable prices. If you are interested, please do not hesitate to send us an inquiry!
Product details:
| Name | Gonadorelin |
| Specification | 2mg/vial, 10mg/vial |
| CAS | 33515-09-2 |
| M.F. | C55-H75-N17-O13 |
| M.W. | 1182 |
| Assay | 98% |
| Appearance | White Lyophilized Powder |
| Storage | Lyophilized peptides although stable at room temperature for 3 months, should be stored desiccated below -18 C. Upon reconstitution of the peptide it should be stored at 4 C between 2-21 days and for future use below -18 C. |
Description:
Gonadorelin is responsible for the release of follicle stimulating hormone and leutinizing hormone from the anterior pitutitary. In the pituitary GnRH stimulates synthesis and release of FSH and LH, a process that is controlled by the frequency and amplitude of GnRH pulses, as well as the feedback of androgens and estrogens. The pulsatility of GnRH secretion has been seen in all vertebrates, and it is necessary to ensure a correct reproductive function. Thus a single hormone, GnRH, controls a complex process of follicular growth, ovulation, and corpus luteum maintenance in the female, and spermatogenesis in the male. Its short half life requires infusion pumps for its clinical use.
Application:
Gonadorelin is another name for gonadotropin-releasing hormone (GnRH). It is a synthetic decapeptide prepared using solid phase peptide synthesis. GnRH is responsible for the release of follicle stimulating hormone and leutinizing hormone from the anterior pitutitary.
GnRH is available as gonadorelin hydrochloride(Factrel®)and gonadorelin diacetate tetrahydrate(Cystorelin®)for injectable use. Studies have described it being used via an infusion pump system to induce ovulation in patients with hypothalamic hypogonadism. It is also used in veterinary medicine as a treatment for cattle with cystic ovarian disease.
Gonadorelin is responsible for the release of follicle stimulating hormone and leutinizing hormone from the anterior pitutitary. In the pituitary GnRH stimulates synthesis and release of FSH and LH, a process that is controlled by the frequency and amplitude of GnRH pulses, as well as the feedback of androgens and estrogens. The pulsatility of GnRH secretion has been seen in all vertebrates, and it is necessary to ensure a correct reproductive function. Thus a single hormone, GnRH, controls a complex process of follicular growth, ovulation, and corpus luteum maintenance in the female, and spermatogenesis in the male. Its short half life requires infusion pumps for its clinical use.
For evaluating the functional capacity and response of the gonadotropes of the anterior pituitary also for evaluating residual gonadotropic function of the pituitary following removal of a pituitary tumor by surgery and/or irradiation.
Gonadorelin is used by women who are missing menstrual periods due to low levels of gonadotropin-releasing hormone (GnRH). It may be used as part of female infertility treatment. This medication provides GnRH that the body needs for the growth and release of mature eggs from the ovaries (ovulation).
Systemic - Like naturally occurring releasing hormone (GnRH), gonadorelin primarily stimulates the synthesis and release of luteinizing hormone (LH) from the anterior pituitary gland. Follicle-stimulating hormone (FSH) production and release is also increased by gonadorelin, but to a lesser degree. In prepubertal females and some gonadal function disorders, the FSH response may be greater than the LH response. For the treatment of amenorrhea, delayed puberty, and infertility the administration of gonadorelin is used to simulate the physiologic release of GnRH from the hypothalamus in treatment of delayed puberty, treatment of infertility caused by hypogonadotropic hypogonadism, and induction of ovulation in those women with hypothalamic amenorrhea. This results in increased levels of pituitary LH and FSH, which subsequently stimulate the gonads to produce reproductive steroids.
Email:doublewin-eunice@nandrolonesteroid.com
WhatsApp:+86 17683962426
Skype:eunice1998